Inches-A-Weigh vs Pritikin Franchise Comparison

Below is an in-depth analysis and side-by-side comparison of Inches-A-Weigh vs Pritikin including start-up costs and fees, business experience requirements, training & support and financing options.

Start-Up Costs and Fees

 
Inches-A-Weigh Franchise
Pritikin Franchise
Investment $65,000 - $125,000$26,069 - $70,713
Franchise Fee $30,500N/A
Royalty Fee -17.5%
Advertising Fee --
Year Founded -2013
Year Franchised -2013
Term Of Agreement --
Term Of Agreement --
Renewal Fee --


Business Experience Requirements

 
Inches-A-Weigh Franchise
Pritikin Franchise
Experience --

Financing Options

 
Inches-A-Weigh Franchise
Pritikin Franchise
  In-House/3rd PartyIn-House/3rd Party
Franchise Fees -/--/-
Start-up Costs -/--/-
Equipment -/--/-
Inventory -/--/-
Receivables -/--/-
Payroll -/--/-

Training & Support

 
Inches-A-Weigh Franchise
Pritikin Franchise
Training --
Support --
Marketing --
Operations --

Expansion Plans

 
Inches-A-Weigh Franchise
Pritikin Franchise
US Expansion --
Canada Expansion --
International Expansion --

Company Overviews

About Inches-A-Weigh

NO LONGER FRANCHISING

About Pritikin

"pritikin
Pritikin offers licenses under which health care providers such as hospitals and cardiology practices can become certified to operate a portion of their existing health care business as a “Pritikin-certified” provider. “Pritikin-certified” programs offer and teach intensive cardiac rehabilitation programs to their patients using Pritikin’s proprietary “Pritikin” intensive cardiac rehabilitation program. These health care providers will conduct the Pritikin-certified Program for patients at their existing health care facilities.
The Pritikin Program is proven to prevent, control, or reverse risk factors for a multiplicity of diseases, ailments, and conditions including:
-Heart Disease, Angina Pain, Hypertension, Type 2 Diabetes, Metabolic Syndrome, Insulin Resistance, Excess Weight/Obesity, Prostate Cancer, Breast Cancer,
Colon Cancer, High Cholesterol, High Triglycerides, Peripheral Artery Disease, Benign Prostatic Hyperplasia and Chronic Inflammation.